Compare LGND & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGND | LMND |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | United States | United States |
| Employees | 68 | 1282 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | LGND | LMND |
|---|---|---|
| Price | $253.97 | $57.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $256.29 | $70.86 |
| AVG Volume (30 Days) | 159.7K | ★ 1.4M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.25 | $65.20 |
| Revenue Next Year | $19.41 | $33.31 |
| P/E Ratio | $76.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $111.72 | $35.70 |
| 52 Week High | $258.57 | $99.90 |
| Indicator | LGND | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 72.06 | 54.53 |
| Support Level | $199.97 | $50.11 |
| Resistance Level | N/A | $59.39 |
| Average True Range (ATR) | 7.35 | 3.72 |
| MACD | 2.29 | 0.41 |
| Stochastic Oscillator | 86.05 | 72.32 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.